资讯
Cover Media US on MSN1 小时
'Fat freezing' treatment found to be safe and effective way to lose weightThe comprehensive study into cryolipolysis - the popular non-surgical fat reduction treatment commonly referred to as "fat freezing" - has been published in the peer-reviewed journal Obesity Review.
Frontiers in Oncology published the largest meta-analysis ever conducted on medical cannabis and its effects on cancer-related symptoms?a groundbreaking scientific achievement. Led by Cancer Playbook, ...
After a months-long pause, advisory councils for the National Institutes of Health are restarting, paving the way for the final approval of grants. Experts say it’s an encouraging sign for the ...
I’ve been sitting on my hands over the topic of assisted dying. Not because I’m scared, or irritated, or confused. I’ve purposely not spoken out owing to something much more serious. Because of my ...
2 小时
Health on MSNHow To Treat Your Ear Infection at HomeEar infections often resolve on their own, but they can be pretty painful. Home remedies can help, like pain relievers, compresses, rest, and staying hydrated.
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of ...
The field of hard and soft tissue regeneration in dentistry has seen significant advancements driven by the increasing ...
Every patient in the trial has met the primary safety endpoint, confirmed through PET imaging showing precise retention of the therapeutic Yttrium-90 isotope at the injection site—with no observed ...
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group. The company plans to ...
Oxidative stress is a fundamental concern in the field of biomedical research, resulting from an imbalance between reactive oxygen species (ROS) production ...
Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for the majority of primary liver cancer cases. It is the fourth ...
Pfizer to discontinue development of danuglipron, an oral GLP- receptor agonist for chronic weight management: New York Wednesday, April 16, 2025, 13:00 Hrs [IST] Pfizer Inc. anno ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果